The Gold-to-Silver Ratio: A Truly Generational Opportunity

This week’s Gong Show in the global financial markets reminds me of the early 1980s before the advent of the Internet or online trading or blogs and especially before 30-something financial “advisors” were allowed to go on the national (and international) airwaves or Internet websites and babble on for what seem like days how “The Fed has our back!” as an excuse for buying stocks at 23 times forward earnings. Back then, at 4:15 every Friday night, there would be a line-up of brokers and analysts (even the janitor) next to the old teletype machine (I am imagining more than a few raised eyebrows among the kids out there as they quickly Google search “teletype machine” on their Smartphones while sipping a $10 cup of fancy-ass coffee) in expectation of the all-important “Money Supply” numbers that everyone supposed was going to give them a hint as to when interest rates would start to decline from 16%-plus nosebleed levels of the early 1980s. Today, it’s essentially the same except the teletype machine has been replaced by Janet Yellen and the ribbon of paper giving us the money supply figures is now Janet Yellen’s tongue giving us the all-omnipotent clues to the “hawkish-dovish” leanings of the U.S. central bank. However, one thing hasn’t changed: the absolute LUNACY of these obsessions and how the algo-bots seize upon the word clouds and move markets in trillions with every single utterance out of Janet’s mouth. So gold and silver immediately bolted higher along with stocks … Continue reading

ContraVir Pharma (CTRV) Prices Common Stock, Warrants Offering for Proceeds of ~$7M - StreetInsider.com

ContraVir Pharma (CTRV) Prices Common Stock, Warrants Offering for Proceeds of ~$7MStreetInsider.comThe shares of common stock and warrants will be issued separately. The warrants will be exercisable beginning on the date of issuance for a period of five years from the issuance date at an exercise price of $1.70 per share. There is no established …ContraVir Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock And Warrants To Purchase …PR Newswire (press release)ContraVir Pharma Falls on Secondary Offering Pricing24/7 Wall St.ContraVir prices equity offering at discount; shares off 26%Seeking AlphaNews Oracle -Wall Street 24all 32 news articles …read more … Continue reading

ContraVir Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock And Warrants To Purchase ... - PR Newswire (press release)

ContraVir Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock And Warrants To Purchase …PR Newswire (press release)EDISON, N.J., March 29, 2016 /PRNewswire/ — ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV) (“ContraVir” or the “Company”), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today … and more …read more … Continue reading

Gevo (GEVO) Prices $3.5M Common Stock, Warrants Offering - StreetInsider.com

Gevo (GEVO) Prices $3.5M Common Stock, Warrants OfferingStreetInsider.comGevo, Inc. (Nasdaq: GEVO) announced that it has priced its underwritten public offering of common stock and warrants. Gevo announced that it has agreed to sell 3,721,429 Series C units, with each Series C unit consisting of one share of common stock …Gevo Announces Proposed Public Offering of Common Stock and WarrantsNasdaqGevo Prices $3.5 Mln Offering of Stock, Warrants (NASDAQ:GEVO)Sonoran Weekly ReviewBasic Materials Worth Chasing: Precision Drilling (PDS), Gevo (GEVO)ZergwatchSeeking Alpha -Wall Street 24 -Benzingaall 22 news articles …read more … Continue reading

Newmarket Gold's Shares Up 75% in 2016 and That Is Just the Beginning

Newmarket Gold’s shares have appreciated 75% since the beginning of 2016, but CEO Douglas Forster believes that is just the beginning. The company’s storied founders have set their sights on making Newmarket the next high-quality mid-tier gold producer. In this interview with The Gold Report, Forster puts forth his vision of how, starting with the acquisition of Crocodile Gold, he will make that happen. The Gold Report: Newmarket Gold Inc. (NMI:TSX) has a significant, well-known team with a strong track record. What brought all of you together? Doug Forster: The founders of Newmarket Gold are friends. We decided it would be great to work together on a mining opportunity. After gold dropped about $100/ounce ($100/oz) one day in April 2013, we agreed that we had not seen valuations for gold assets at this level for many years. So we decided Newmarket would acquire gold-producing opportunities, and our strategy would be to roll up quality gold production assets. Great gold assets don’t walk through the door. You have to literally dig them up. So having Lukas Lundin, Randall Oliphant, Ray Threlkeld and Blayne Johnson as founders of Newmarket brings an incredible contact base and scope of relationships to our business, which we will leverage to find and acquire those undervalued, potentially unrecognized quality gold assets. Newmarket wants to be the next quality mid-tier gold producer. Our first acquisition, Crocodile Gold Corp., was an unrecognized, undervalued gold production opportunity that our team identified, negotiated terms and closed. It has worked out very … Continue reading

KLR Energy Acquisition Corp. Class A Common Stock and Warrants to Commence Separate Trading - BOE Report (press release)

KLR Energy Acquisition Corp. Class A Common Stock and Warrants to Commence Separate TradingBOE Report (press release)HOUSTON, March 28, 2016 /PRNewswire/ — KLR Energy Acquisition Corp. (the “Company”) announced today that holders of the Company’s units may elect to separately trade the shares of Class A common stock (the “Shares”) and warrants (the “Warrants”) … and more …read more … Continue reading

BioPharmX Corporation Announces Proposed Public Offering of Common Stock and Warrants - PR Newswire (press release)

BioPharmX Corporation Announces Proposed Public Offering of Common Stock and WarrantsPR Newswire (press release)The common stock and warrants are being offered under the company’s effective shelf registration statement previously filed with the Securities and Exchange Commission (SEC). BioPharmX intends to use the net proceeds of the offering for general …BioPharmX Tumbles 21%, Plans to Sell Shares and Warrants (NYSEMKT:BPMX)Sonoran Weekly Review all 3 news articles …read more … Continue reading